Drug recall · April 9, 2014
Tivicay recall
Why: Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13
- Lots / codes
Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
- Quantity
- 1,056 bottles
- Company
- Viiv Healthcare Company, Durham, NC
- Distribution
- Nationwide including Puerto Rico
- Initiated
- February 11, 2014 · Voluntary: Firm initiated
- Classified
- April 1, 2014
- Reported
- April 9, 2014
- Ended
- August 21, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tivicay
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.